Resultados da busca - Colleen M. Niswender
- Mostrando 1 - 20 resultados de 69
- Ir para a próxima página
-
1
-
2
-
3
Metabotropic Glutamate Receptors: Physiology, Pharmacology, and Disease por Colleen M. Niswender, P. Jeffrey Conn
Publicado em 2010Revisão -
4
-
5
Novel pharmacological targets for GABAergic dysfunction in ADHD por Anthony S. Ferranti, Deborah J. Luessen, Colleen M. Niswender
Publicado em 2024Revisão -
6
-
7
Glutamate Receptors as Therapeutic Targets for Parkinsons Disease por Kari A. Johnson, P. Jeffrey Conn, Colleen M. Niswender
Publicado em 2009Revisão -
8
-
9
-
10
-
11
-
12
-
13
Discovery of a Novel Chemical Class of mGlu<sub>5</sub> Allosteric Ligands with Distinct Modes of Pharmacology por Alexis S. Hammond, Alice L. Rodriguez, Steven D. Townsend, Colleen M. Niswender, Karen J. Gregory, Craig W. Lindsley, P. Jeffrey Conn
Publicado em 2010Artigo -
14
Practical Strategies and Concepts in GPCR Allosteric Modulator Discovery: Recent Advances with Metabotropic Glutamate Receptors por Craig W. Lindsley, Kyle A. Emmitte, Corey R. Hopkins, Thomas M. Bridges, Karen J. Gregory, Colleen M. Niswender, P. Jeffrey Conn
Publicado em 2016Revisão -
15
Total RNA Sequencing of Rett Syndrome Autopsy Samples Identifies the M<sub>4</sub> Muscarinic Receptor as a Novel Therapeutic Target por Rocco G. Gogliotti, Nicole M. Fisher, Branden J. Stansley, Carrie K. Jones, Craig W. Lindsley, P. Jeffrey Conn, Colleen M. Niswender
Publicado em 2018Artigo -
16
Selective Actions of Novel Allosteric Modulators Reveal Functional Heteromers of Metabotropic Glutamate Receptors in the CNS por Yin Shen, Meredith J. Noetzel, Kari A. Johnson, Rocio Zamorano, Nidhi Jalan‐Sakrikar, Karen J. Gregory, P. Jeffrey Conn, Colleen M. Niswender
Publicado em 2013Artigo -
17
Allosteric Modulation of Seven Transmembrane Spanning Receptors: Theory, Practice, and Opportunities for Central Nervous System Drug Discovery por Bruce J. Melancon, Corey R. Hopkins, Michael R. Wood, Kyle A. Emmitte, Colleen M. Niswender, Arthur Christopoulos, P. Jeffrey Conn, Craig W. Lindsley
Publicado em 2011Artigo -
18
Metabotropic glutamate receptor 3 activation is required for long-term depression in medial prefrontal cortex and fear extinction por Adam G. Walker, Cody J. Wenthur, Zixiu Xiang, Jerri M. Rook, Kyle A. Emmitte, Colleen M. Niswender, Craig W. Lindsley, P. Jeffrey Conn
Publicado em 2015Artigo -
19
A Novel Class of Succinimide-Derived Negative Allosteric Modulators of Metabotropic Glutamate Receptor Subtype 1 Provides Insight into a Disconnect in Activity between the Rat and... por Hyekyung P. Cho, Darren W. Engers, Daryl F. Venable, Colleen M. Niswender, Craig W. Lindsley, P. Jeffrey Conn, Kyle A. Emmitte, Alice L. Rodriguez
Publicado em 2014Artigo -
20
Synthesis and Evaluation of a Series of Heterobiarylamides That Are Centrally Penetrant Metabotropic Glutamate Receptor 4 (mGluR4) Positive Allosteric Modulators (PAMs) por Darren W. Engers, Colleen M. Niswender, C. David Weaver, Satyawan Jadhav, Usha N. Menon, Rocio Zamorano, P. Jeffrey Conn, Craig W. Lindsley, Corey R. Hopkins
Publicado em 2009Artigo
Ferramentas de busca:
Assuntos relacionados
Receptor
Biology
Neuroscience
Biochemistry
Allosteric regulation
Chemistry
Pharmacology
Allosteric modulator
Glutamate receptor
Metabotropic glutamate receptor
Medicine
Metabotropic receptor
Psychology
Agonist
Internal medicine
Metabotropic glutamate receptor 5
Muscarinic acetylcholine receptor
Psychiatry
Metabotropic glutamate receptor 1
Genetics
Metabotropic glutamate receptor 2
Schizophrenia (object-oriented programming)
Acetylcholine
Dopamine
Drug discovery
In vivo
Muscarinic acetylcholine receptor M1
NMDA receptor
Cognition
Long-term potentiation